QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.12) per share. This is a 300 percent decrease over losses o...

Core News & Articles

Key partnerships, regulatory  progress, manufacturing advancements, along with significant capital infusion accelerate the deve...

Core News & Articles

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity IndicatorsNEW YORK, July 24, 2025 /...

Core News & Articles

-SEC Filing

 klotho-clears-nasdaq-hurdleklto-stock-remains-on-the-big-board

Klotho Neurosciences' stock has full compliance with all continued listing requirements and will remain listed and traded o...

Core News & Articles

Klotho Neurosciences, Inc. ("Klotho" or the "Company") (NASDAQ: KLTO), a gene and cell therapy company focused ...

 klotho-stock-delivers-1222-biotech-blowout-opportunity-or-bubble

Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

 us-stocks-likely-to-open-lower-a-day-after-nasdaq-hits-record-high-nvidia-kellogg-klotho-in-focus

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

 this-penny-stock-exploded-500-in-june-what-you-need-to-know

Shares of the anti-aging biogenetics company Klotho Neurosciences are on retail investors' radars after the stock exploded ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION